• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Which Metabolites are Involved in the Pathogenesis of Atherosclerotic Disease in NAFLD?哪些代谢物参与了非酒精性脂肪性肝病（NAFLD）中动脉粥样硬化疾病的发病机制？
J Atheroscler Thromb. 2024 Jul 1;31(7):1024-1025. doi: 10.5551/jat.ED260. Epub 2024 Apr 19.
2
Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis.非酒精性脂肪性肝病：促进动脉粥样硬化的代谢负担。
Clin Sci (Lond). 2020 Jul 17;134(13):1775-1799. doi: 10.1042/CS20200446.
3
NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?非酒精性脂肪性肝病与动脉粥样硬化：同一代谢紊乱之两面？
Trends Endocrinol Metab. 2019 Dec;30(12):891-902. doi: 10.1016/j.tem.2019.08.008. Epub 2019 Oct 17.
4
Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.非酒精性脂肪性肝病与动脉粥样硬化关系的研究进展
Lipids Health Dis. 2015 Dec 3;14:158. doi: 10.1186/s12944-015-0141-z.
5
Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation.胆固醇诱导的非酒精性脂肪性肝病和动脉粥样硬化因全身炎症而加重。
PLoS One. 2014 Jun 5;9(6):e97841. doi: 10.1371/journal.pone.0097841. eCollection 2014.
6
LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.LDL-迁移指数（LDL-MI），一种小而密低密度脂蛋白（sdLDL）的指标，在非酒精性脂肪性肝炎中高于非酒精性脂肪肝：一项多中心横断面研究。
PLoS One. 2014 Dec 26;9(12):e115403. doi: 10.1371/journal.pone.0115403. eCollection 2014.
7
Association of Nonalcoholic Fatty Liver Disease with Arterial Stiffness and its Metabolomic Profiling in Japanese Community-Dwellers.非酒精性脂肪肝疾病与动脉僵硬及其在日本社区居民中的代谢组学特征的关联。
J Atheroscler Thromb. 2024 Jul 1;31(7):1031-1047. doi: 10.5551/jat.64616. Epub 2024 Feb 2.
8
Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: A cross-sectional study.非酒精性脂肪性肝病在动脉粥样硬化患者中代表着更大的代谢负担：一项横断面研究。
Medicine (Baltimore). 2019 Mar;98(11):e14896. doi: 10.1097/MD.0000000000014896.
9
Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.心肌FDG摄取减少的非酒精性脂肪性肝病与冠状动脉粥样硬化有关。
J Nucl Cardiol. 2021 Apr;28(2):610-620. doi: 10.1007/s12350-019-01736-6. Epub 2019 May 10.
10
Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.氧化应激作为非酒精性脂肪性肝病发病机制中的关键因素
Antioxid Redox Signal. 2017 Apr 1;26(10):519-541. doi: 10.1089/ars.2016.6776. Epub 2016 Aug 30.

本文引用的文献

1
Association of Nonalcoholic Fatty Liver Disease with Arterial Stiffness and its Metabolomic Profiling in Japanese Community-Dwellers.非酒精性脂肪肝疾病与动脉僵硬及其在日本社区居民中的代谢组学特征的关联。
J Atheroscler Thromb. 2024 Jul 1;31(7):1031-1047. doi: 10.5551/jat.64616. Epub 2024 Feb 2.
2
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.2014年至2018年日本普通人群中非酒精性脂肪性肝病的患病率及相关代谢因素：一项大规模多中心回顾性研究。
Hepatol Res. 2023 Nov;53(11):1059-1072. doi: 10.1111/hepr.13947. Epub 2023 Aug 28.
3
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病（NAFLD）和非酒精性脂肪性肝炎（NASH）的全球流行病学：系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
4
Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study.亚临床动脉粥样硬化的血浆代谢组学分析：糖尿病心脏研究。
Cardiovasc Diabetol. 2021 Dec 7;20(1):231. doi: 10.1186/s12933-021-01419-y.
5
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.非酒精性脂肪性肝病的代谢组学和脂质组学：生物标志物和非侵入性诊断检测。
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):835-856. doi: 10.1038/s41575-021-00502-9. Epub 2021 Sep 10.
6
Associations between serum metabolites and subclinical atherosclerosis in a Chinese population: the Taizhou Imaging Study.中国人群血清代谢物与亚临床动脉粥样硬化的相关性：台州影像学研究。
Aging (Albany NY). 2020 Jul 9;12(15):15302-15313. doi: 10.18632/aging.103456.
7
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.非酒精性脂肪性肝病与心血管疾病发病风险：荟萃分析。
J Hepatol. 2016 Sep;65(3):589-600. doi: 10.1016/j.jhep.2016.05.013. Epub 2016 May 17.
8
NAFLD: a multisystem disease.非酒精性脂肪性肝病：一种多系统疾病。
J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012.
9
Metabolite profiles and the risk of developing diabetes.代谢产物谱与糖尿病发病风险。
Nat Med. 2011 Apr;17(4):448-53. doi: 10.1038/nm.2307. Epub 2011 Mar 20.

Which Metabolites are Involved in the Pathogenesis of Atherosclerotic Disease in NAFLD?

作者信息

Tanno Kozo

机构信息

Department of Hygiene and Preventive Medicine, School of Medicine, Iwate Medical University.

出版信息

J Atheroscler Thromb. 2024 Jul 1;31(7):1024-1025. doi: 10.5551/jat.ED260. Epub 2024 Apr 19.

DOI:10.5551/jat.ED260
PMID:38644202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11224696/
Abstract
摘要